{
  "abstract": "This workshop aims to provide solutions for inappropriate overtreatment in older people. Polypharmacy is prevalent among older people. While some medicines are clinically indicated, polypharmacy in older people is associated with an increased risk of hospitalisations, functional impairment, geriatric syndromes (including confusion, falls, incontinence, frailty) and mortality. Adverse drug events are frequently under-recognised and can be mistaken for symptoms requiring further treatment, which leads to inappropriate prescribing cascades or may be dismissed as an unavoidable consequence of ageing. Existing clinical practice guidelines are largely single-disease-focused and do not reflect the reality of multimorbidity (the presence of two or more chronic health conditions) in practice. The management of multimorbidity is often complex. Strictly following all the recommendations in current single-disease guidelines without incorporating individual preferences and circumstances can result in an overwhelming treatment burden for older people with multimorbidity. The absence of clinical guidelines for deprescribing in older people has consistently been identified as a barrier to deprescribing.We have developed a clinical practice guideline as a resource for healthcare providers to guide the deprescribing of common medicines prescribed for older people. Our multidisciplinary team consists of medical practitioners, allied health professionals, researchers, patients, and policymakers who want to raise awareness and find solutions to the problem of too much medicine. This guideline was developed following the Australian National Health and Medical Research Council Guideline Development Methodology and the Appraisal of Guidelines for Research & Evaluation (AGREE) II Instrument and User’s Manual. This guideline targeted polypharmacy and 34 most commonly dispensed drug classes for older people.The recommendations and practice points included in this guideline are intended as practical guidance to help prescribers decide with their patients which long-term medicines can be considered for deprescribing. It provides a summary of recommendations for when, how and for whom deprescribing may be considered and offered, with a shared decision-making process involving patients, their family members, carers, or support persons to ensure decisions align with individual health goals, values, and preferences. Additionally, this guideline identifies monitoring requirements during the deprescribing process and addresses ongoing treatment needs as applicable. We propose this session to workshop the application of the guidelines in clinical care using case studies.Objectives:Introduce the concept and outcomes of deprescribing as well as the role of prescribers in over-treatmentDiscuss the application of deprescribing guidelines for common medicines used by older peopleDemonstrate how to incorporate patient-centred care principles and shared decision-making into the deprescribing process.Learning outcomes: After completing this workshop, participants should be able to:Understand the concept and outcomes of deprescribingIdentify situations where deprescribing may be appropriate and inappropriate, how to deprescribe, and monitoring requirements following deprescribing.Apply patient-centred care and shared decision-making in deprescribingProposed format:Interactive workshop in small groups to apply guidelines to realistic case scenariosGroup discussion to identify deprescribing opportunities, overcome potential barriers, and provide insights and recommendations to peers and presenters",
  "authors": [
    {
      "affiliations": [
        "Centre for Optimisation of Medicines, School of Allied Health, The University of Western Australia, Perth, Australia"
      ],
      "name": "Hui Wen Quek"
    },
    {
      "affiliations": [
        "Centre for Optimisation of Medicines, School of Allied Health, The University of Western Australia, Perth, Australia"
      ],
      "name": "Amy Page"
    },
    {
      "affiliations": [
        "Centre for Optimisation of Medicines, School of Allied Health, The University of Western Australia, Perth, Australia"
      ],
      "name": "Xisco Reus"
    },
    {
      "affiliations": [
        "Western Australian Centre for Health and Ageing, The University of Western Australia and Royal Perth Hospital, Perth, Australia"
      ],
      "name": "Christopher Etherton-Beer on behalf of the guideline development group"
    }
  ],
  "title": "038 Too much medicine in older people: practical strategies for applying deprescribing guidelines in clinical care",
  "uid": "bd2afa6e-48ed-5056-9f22-e4c245859742"
}